Oppenheimer Reiterates Outperform Rating, $6 Price Target on CASI Pharmaceuticals (CASI) Following Company's Q1 Update
Go back to Oppenheimer Reiterates Outperform Rating, $6 Price Target on CASI Pharmaceuticals (CASI) Following Company's Q1 Update| Careside, Inc. (NASDAQ: CASI) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $1.70 | |||
| Open | $0.21 | 52 Week Low | $0.58 | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $0.00 | |||
| Volume | 26 | |||||

